April 30th, 2026

The call presents a mixed picture: operationally and strategically Nutex demonstrates strong liquidity, improved net income, positive cash flow, active share repurchases, patient satisfaction, and a clear strategy to internalize development and scale population health. However, significant margin pressure and a 21% drop in adjusted EBITDA driven by higher facility costs and timing effects from IDR/arbitration recognition temper the results. Same-hospital revenue growth was minimal and accounts receivable rose, highlighting near-term execution and working capital considerations. Regulatory and arbitration accounting dynamics introduce additional volatility. Overall, positive cash generation and strategic initiatives are balanced by meaningful margin and accounting headwinds.

Company Guidance

Management guided that Nutex remains on track to expand meaningfully in 2026–27, reiterating plans to open three hospitals in Q3–Q4 2026 (San Antonio, Jacksonville and West Little Rock), to internally develop projects that typically take 18–24 months and cost roughly $20–$30 million apiece, and to target roughly 3–5 new hospitals per year while monetizing assets via sale‑leasebacks; they expect arbitration/IDR activity to normalize (currently submitting 50%–60% of claims, prevailing in >85% of determinations and collecting >80%, with arbitration-related costs currently higher at ~35% of arbitration revenue but expected to settle into a ~24%–26% range), signaled continued capital returns (completed $25M buyback retiring ~119k shares and initiated a second $25M program), and gave other forward-looking checkpoints including an effective tax rate in the high‑teens to ~20% range, ongoing investments in AI/IT and IPA insourcing, and reliance on a strong liquidity and balance sheet position (cash $207.3M, net cash from operations $75.5M, net long‑term debt down to $24.3M) alongside current operating metrics (Q1 revenue $216.5M, hospital revenue $207.6M, adjusted EBITDA $57.6M, net income $46.8M, visits 49,742 up 3.1%).